Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity

被引:0
|
作者
Rosenstock, Julio
Coskun, Tamer
Hartman, Mark L.
Lou, Jitong
Wu, Qiwei
Du, Yu
Gurbuz, Sirel
Mather, Kieren J.
Milicevic, Zvonko
Thomas, Melissa K.
机构
关键词
D O I
10.2337/db24-266-OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
266-OR
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Highly efficient detection of insulinotropic action of glucagon via GLP-1 receptor in mice pancreatic beta-cell with a novel perfusion microchip
    Li-Dan Hu
    Yu-Lin Zhang
    Hong Wang
    Xing-Yue Peng
    Yi Wang
    ChineseChemicalLetters, 2016, 27 (07) : 1027 - 1031
  • [42] Highly efficient detection of insulinotropic action of glucagon via GLP-1 receptor in mice pancreatic beta-cell with a novel perfusion microchip
    Hu, Li-Dan
    Zhang, Yu-Lin
    Wang, Hong
    Peng, Xing-Yue
    Wang, Yi
    CHINESE CHEMICAL LETTERS, 2016, 27 (07) : 1027 - 1031
  • [43] AMYLIN ALTERS BIOLOGICAL EFFECTS OF GLP-1 IN THE BETA-CELL
    GOKE, R
    MCGREGOR, GP
    GOKE, B
    DIGESTION, 1993, 54 (06) : 355 - 356
  • [44] Insulin requirements after switching from GLP-1 receptor agonist to dual GIP/GLP-1 receptor agonist in patients with type 2 diabetes mellitus
    Lahey, Alexa M.
    Duprey, Karolyn
    Montague, Riley C.
    Schadler, Aric D.
    Naseman, Kristina W.
    PHARMACOTHERAPY, 2025,
  • [45] Blockade of Cannabinoid 1 Receptor Improves Pancreatic Beta-Cell Function
    Han, Ji Hye
    Shin, Hanho
    Kim, Wook
    DIABETES, 2017, 66 : LB91 - LB91
  • [46] Activation of Trpm2 Channel by Glucose Metabolism and GLP-1 in Pancreatic Beta-Cell
    Yoshida, Masashi
    Yamato, Shiho
    Dezaki, Katsuya
    Kawakami, Masanobu
    Yada, Toshihiko
    Kakei, Masafumi
    DIABETES, 2013, 62 : A572 - A572
  • [47] Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
    Tura, Andrea
    Pacini, Giovanni
    Yamada, Yuchiro
    Seino, Yutaka
    Ahren, Bo
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2019, 316 (01) : R27 - R37
  • [48] Indices of beta-cell function: association with diabetes control in patients with type 2 diabetes on stable GLP-1 agonist treatment
    Behary, Preeshila
    Godsland, Ian F.
    Baynes, Kevin C.
    PRACTICAL DIABETES, 2014, 31 (05) : 202 - 205
  • [49] A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor (vol 20, 3532, 2019)
    Al-Zamel, Noura
    Al-Sabah, Suleiman
    Luqmani, Yunus
    Adi, Lobna
    Chacko, Siby
    Schneider, Tom Dario
    Krasel, Cornelius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [50] PANCREATIC ISLET GLP-1 SECRETION IS INCREASED IN NON-DIABETIC OBESITY AND GLP-1 DIRECTLY REGULATES BETA-CELL CHOLECYSTOKININ PRODUCTION
    Linnemann, A. K.
    Battiola, T. J.
    Kimple, M. E.
    Davis, D. B.
    Neuman, J. C.
    Davis, D. B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (04) : 667 - 667